Rybelsus (Semaglutide) – The First Oral GLP-1 Treatment for Type 2 Diabetes
Rybelsus is a groundbreaking prescription medication used to help adults manage type 2 diabetes. As the first oral GLP-1 receptor agonist, Rybelsus helps lower blood sugar by stimulating insulin release, decreasing glucagon, and slowing gastric emptying. It supports weight management and improved A1C levels when combined with a healthy diet and regular exercise. With the convenience of a once-daily pill, Rybelsus offers an effective and easy-to-use alternative to injections, helping reduce the risk of long-term diabetes complications.
-
-4%Rybelsus 14 mg
Original price was: $1,077.00.$1,035.00Current price is: $1,035.00.Add to cartTake your weight loss or blood sugar management further with Rybelsus 14 mg, the highest available strength of this once-daily oral GLP-1 receptor agonist. Designed for adults with type 2 diabetes or obesity-related conditions, it helps lower A1C, control appetite, and support long-term metabolic health. Easy to take without injections.
-
-4%Rybelsus 3 mg
Original price was: $1,077.00.$1,035.00Current price is: $1,035.00.Add to cartRybelsus 3 mg is the recommended starting dose for patients beginning oral GLP-1 therapy. This once-daily tablet helps your body adjust to the medication while offering early benefits in appetite control and blood sugar regulation. Often used for the first 30 days before transitioning to a higher dose.
-
-4%Rybelsus 7 mg
Original price was: $1,077.00.$1,035.00Current price is: $1,035.00.Add to cartRybelsus 7 mg offers a convenient oral GLP-1 solution for those progressing in their diabetes or weight loss treatment. Taken once daily, it works by mimicking natural hormones to regulate blood sugar, reduce appetite, and aid in weight control — without the need for injections.